Latest Rhinitis Stories

2010-06-07 07:28:00

LONDON, June 7, 2010 /PRNewswire-FirstCall/ -- Data published at the European Allergy, Asthma & Clinical Immunology (EAACI) congress in London today documents that GRAZAX(R) is the only allergy immunotherapy tablet (AIT) to show sustained disease control 2 years after treatment completion.

2010-05-25 08:33:00

CARY, N.C., May 25 /PRNewswire/ -- Cetero Research, the leading early-stage contract research organization (CRO), announced today that it has more Environmental Exposure Chambers (EECs), or allergy models for recreating environmental conditions than any other CRO.

2010-04-19 01:44:00

ANTONY, France, April 19, 2010 /PRNewswire-FirstCall/ -- Stallergenes S.A.

2010-03-19 11:37:00

FT. WASHINGTON, Pa., March 19 /PRNewswire/ -- Allergy sufferer and actress Alison Sweeney today joined the makers of the fastest 24-hour over-the-counter (OTC) allergy medicine, ZYRTEC®, for an unusual race to officially welcome the first day of spring and new ZYRTEC® Liquid Gels.

2010-03-15 15:34:00

MISSISSAUGA, ON, March 15 /PRNewswire-FirstCall/ - Nuvo Research Inc.

2010-03-10 07:57:00

BRIDGEWATER, N.J., March 10 /PRNewswire/ -- Sanofi-aventis U.S. today announced the launch of the Clean Sweep campaign to help guide spring cleaning for the estimated 60 million Americans who are affected by nasal allergies.

2010-03-01 13:20:24

Doctors from Italy are saying that pollen seasons may be longer due to changes in climate patterns, causing an extended period of congestion and sneezing for people with allergies, especially hay fever.

2010-02-13 11:29:00

AUSTIN, Texas, Feb. 13 /PRNewswire/ -- The beauty of budding plants and bouquet of aromas are sources of satisfaction for many gardeners.

2010-02-12 07:00:00

Medication Delivered Under the Tongue May Be Alternative to Allergy Shots PITTSBURGH, Feb.

2010-02-12 03:00:00

OXFORD, England, February 12 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial.

Word of the Day
  • An uxorious, effeminate, or spiritless man.
  • A timorous, cowardly fellow.
Probably a blend of meek and cock, or from meek +‎ -ock (“diminutive suffix”).